Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Olanow

Showing results (71-80 of 124) with videos related to

Pageof 13
Sort By:
Annals of Neurology|April 13, 2000
Pathophysiology of levodopa-induced dyskinesias in Parkinson's disease: problems with the current modelJ A Obeso, M C Rodriguez-Oroz, M Rodriguez, et al.
Annals of Neurology|September 28, 1998
A fluorescent double-labeling method to detect and confirm apoptotic nuclei in Parkinson's diseaseN A Tatton, A Maclean-Fraser, W G Tatton, et al.
Biological Trace Element Research|December 24, 1997
Intranigral iron infusion in the rat. Acute elevations in nigral lipid peroxidation and striatal dopaminergic markers with ensuing nigral degenerationG J Sengstock, N H Zawia, C W Olanow, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|October 14, 2004
Effects of levodopa on cognitive functioning in moderate-to-severe Parkinson's disease (MSPD)C E Morrison, J C Borod, M F Brin, et al.
Journal of Neuroscience Research|May 1, 1993
Infusion of iron into the rat substantia nigra: nigral pathology and dose-dependent loss of striatal dopaminergic markersG J Sengstock, C W Olanow, R A Menzies, et al.
The American Journal of Psychiatry|December 1, 1981
"On-off" syndrome treated with lithium carbonate: a case reportD R Ross, C E Coffey, E L Ferren, et al.
Annals of Neurology|October 1, 1982
Treatment of the "on-off" phenomenon in Parkinsonism with lithium carbonateC E Coffey, D R Ross, E L Ferren, et al.
Neurology|January 9, 2001
The evolution and origin of motor complications in Parkinson's diseaseJ A Obeso, M C Rodriguez-Oroz, P Chana, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|June 1, 2000
Time course of loss of clinical benefit following withdrawal of levodopa/carbidopa and bromocriptine in early Parkinson' s diseaseR A Hauser, W C Koller, J P Hubble, et al.
Archives of Neurology|October 13, 2004
Double-blind, placebo-controlled study of entacapone in levodopa-treated patients with stable Parkinson diseaseC W Olanow, K Kieburtz, M Stern, et al.
Pageof 13

Showing results (71-80 of 124) with videos related to

Sort By:
Pageof 13
Annals of Neurology|April 13, 2000
Pathophysiology of levodopa-induced dyskinesias in Parkinson's disease: problems with the current modelJ A Obeso, M C Rodriguez-Oroz, M Rodriguez, et al.
Annals of Neurology|September 28, 1998
A fluorescent double-labeling method to detect and confirm apoptotic nuclei in Parkinson's diseaseN A Tatton, A Maclean-Fraser, W G Tatton, et al.
Biological Trace Element Research|December 24, 1997
Intranigral iron infusion in the rat. Acute elevations in nigral lipid peroxidation and striatal dopaminergic markers with ensuing nigral degenerationG J Sengstock, N H Zawia, C W Olanow, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|October 14, 2004
Effects of levodopa on cognitive functioning in moderate-to-severe Parkinson's disease (MSPD)C E Morrison, J C Borod, M F Brin, et al.
Journal of Neuroscience Research|May 1, 1993
Infusion of iron into the rat substantia nigra: nigral pathology and dose-dependent loss of striatal dopaminergic markersG J Sengstock, C W Olanow, R A Menzies, et al.
The American Journal of Psychiatry|December 1, 1981
"On-off" syndrome treated with lithium carbonate: a case reportD R Ross, C E Coffey, E L Ferren, et al.
Annals of Neurology|October 1, 1982
Treatment of the "on-off" phenomenon in Parkinsonism with lithium carbonateC E Coffey, D R Ross, E L Ferren, et al.
Neurology|January 9, 2001
The evolution and origin of motor complications in Parkinson's diseaseJ A Obeso, M C Rodriguez-Oroz, P Chana, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|June 1, 2000
Time course of loss of clinical benefit following withdrawal of levodopa/carbidopa and bromocriptine in early Parkinson' s diseaseR A Hauser, W C Koller, J P Hubble, et al.
Archives of Neurology|October 13, 2004
Double-blind, placebo-controlled study of entacapone in levodopa-treated patients with stable Parkinson diseaseC W Olanow, K Kieburtz, M Stern, et al.
Pageof 13